Skip to main content
Caplight Logo









Pulmongene

Pulmongene

Private
BeijingHealthcare & Life Scienceshttps://www.pulmongene.com/

Company Overview

Pulmongene is a clinical-stage biotechnology company that develops first-in-class therapies for pulmonary, fibrotic, and autoimmune diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug discoveryidiopathic pulmonary fibrosisIPFanti-fibrotic therapyclinical trialspulmonary fibrosisbiopharmaorgan fibrosistherapeutic antibodiesprogressive pulmonary fibrosisPPFclinical-stage biotechautoimmune diseasedrug development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pulmongene Comparables

Compare Pulmongene with similar companies based on industry and business-model similarity.

Pulmongene comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Celea Therapeutics
83%
Endeavor BioMedicines
83%
Oorja Bio, Inc.
80%
View all Comparables

Pulmongene Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Pulmongene Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Pulmongene Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Pulmongene's valuation, stock price, and market status.

Firmographic Details

HeadquartersBeijing
Year Founded2019
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?